Peter Atadja - 15 Dec 2022 Form 3 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role
Director
Signature
/s/ Mark Guerin, Attorney-in-Fact
Issuer symbol
TRAW
Transactions as of
15 Dec 2022
Net transactions value
$0
Form type
3
Filing time
19 Dec 2022, 17:50:35 UTC
Next filing
14 Aug 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 attached